Administrative Core A
行政核心A
基本信息
- 批准号:10891051
- 负责人:
- 金额:$ 24.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAdvisory CommitteesAreaAwardBasic ScienceBehavioralBehavioral MechanismsBehavioral SciencesBiologicalBiological Specimen BanksBudgetsBusinessesCareer MobilityCharacteristicsCollaborationsCommunicationCommunitiesCommunity OutreachDevelopmentEducationEducation and OutreachEnsureEnvironmentEpidemiologyEquipment and SuppliesEvaluationFosteringFundingFutureHIVHIV riskHIV therapyHIV/AIDSHuman ResourcesIncidenceIndividualInfectionInformation DisseminationInternationalInvestmentsJointsLaboratoriesLeadershipMedicalMental HealthMental disordersMentorsMissionModelingMonitorNational Institute of Mental HealthOutcomeParticipantPediatric HospitalsPennsylvaniaPerformancePersonsPhiladelphiaPlayPoliciesProceduresProcessResearchResearch ActivityResearch DesignResearch InfrastructureResearch PersonnelResearch PriorityResearch SupportResearch TrainingResource SharingResourcesRoleSafetySchoolsScientistSeriesSocial SciencesStrategic PlanningStructureTrainingUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesWomanWorkbehavioral and social sciencebiobehaviorcareer developmentco-infectioncohesioncollaborative environmentcollaboratorycommunity engagementcomorbiditycostdiversity and inclusionexperienceimplementation scienceimprovedinnovationinterdisciplinary collaborationlensmeetingsnext generationorganizational structureoutreachoutreach programprogramspsychologicsoundsynergism
项目摘要
CORE A: Abstract/Summary
Core A provides leadership, management, organizational structure, fiscal oversight, and scientific direction to
the Penn Mental Health AIDS Research Center (PMHARC), enabling it to fulfill its core mission to transform how
people with both mental illness and HIV are treated and managed, an explicit focus not currently pursued by any
other NIMH AIDS Research Center (ARC). PMHARC is unique in: 1) its scientific focus on mental health issues
in HIV through an integration of basic, biological and social and behavioral sciences; 2) its unique behavioral
and specimen repository and status as the only Behavioral ARC with a Laboratory and Biobehavioral Markers
Core; 3) its development of a successful co-funding model with CFAR for PMHARC pilots; and 4) its status as
the only NIMH Behavioral ARC collaborating with the NIMH Neuro ARCs in the NIMH Joint Seminar Series. The
Center and Core A is led by a Director and two Co-Directors with exceptional and complementary strengths and
experience in administration, research, and training and in the study of comorbid mental illness/HIV. PMHARC
is located in an optimal intellectual and resource environment, which encompasses robust and well-regarded
mental health and HIV research communities on the Penn/CHOP/Wistar contiguous campuses. Through Core
A, PMHARC will continue to optimize psychiatric, behavioral, and medical outcomes for those with comorbid
mental illness/HIV and elucidate the biological, psychological, and behavioral mechanisms underlying these
combined illnesses and treatments. Core A has created an interactive environment that fosters communication,
collaboration, and synergy among Center components and participants, as well as with the relevant schools,
departments, centers, and institutes at Penn/CHOP/Wistar including CFAR, CTSA, Delaney Collaboratories at
Wistar and Temple, and other ARCs. Core A will be engaged and responsible for: 1) coordinating interdisciplinary
and collaborative mental health/HIV research; 2) encouraging, supporting, and mentoring new, established, and
transitional investigators to focus on comorbid mental illness/HIV, and related comorbidities; 3) developing
vibrant and responsive Strategic Planning, Monitoring, and Evaluation Processes and comprehensive Policies
and Procedures; 4) managing fiscal matters; 5) conducting educational and community outreach programs; 6)
fostering national linkages among other ARCs; and 7) supporting an active Community Advisory Board (CAB).
Core A also includes 3 Consultants, Executive Committee (EC), Internal Advisory Board (IAB), External Advisory
Committee (EAC), Research Innovation and Diversity Committee (RIDC), and CAB. This structure is explicitly
intended to allow for continuous monitoring and evaluation in order to optimize efficiencies and responsiveness.
In its first two cycles, PMHARC has made impressive progress in: advancing Diversity/ Inclusion; engaging
investigators in combined HIV/mental health research and promoting research infrastructure; identifying,
mentoring, and promoting career advancement of Early Stage Investigators (ESIs); and producing an impressive
return on investment of the pilot award program.
核心 A:摘要/总结
核心 A 提供领导、管理、组织结构、财政监督和科学指导
宾夕法尼亚州心理健康艾滋病研究中心 (PMHARC),使其能够履行其核心使命,即改变如何
同时患有精神疾病和艾滋病毒的人得到治疗和管理,这是目前任何一个组织都没有明确关注的焦点
其他 NIMH 艾滋病研究中心 (ARC)。 PMHARC 的独特之处在于:1)其对心理健康问题的科学关注
通过整合基础科学、生物科学、社会科学和行为科学来研究艾滋病毒; 2)其独特的行为方式
和标本存储库以及作为唯一具有实验室和生物行为标记的行为 ARC 的地位
核; 3) 与 CFAR 为 PMHARC 试点开发成功的联合资助模式; 4) 其状态为
在 NIMH 联合研讨会系列中,唯一与 NIMH 神经 ARC 合作的 NIMH 行为 ARC。这
中心和核心 A 由一名主任和两名联合主任领导,他们具有卓越且互补的优势,
具有管理、研究和培训以及共病精神疾病/艾滋病毒研究方面的经验。 PMHARC
位于最佳的智力和资源环境中,其中包括强大且备受推崇的
宾夕法尼亚大学/CHOP/Wistar 毗邻校园的心理健康和艾滋病毒研究社区。贯穿核心
答:PMHARC 将继续优化患有共病患者的精神、行为和医疗结果
精神疾病/艾滋病毒,并阐明这些疾病背后的生物、心理和行为机制
结合疾病和治疗。核心A创造了一个促进沟通的互动环境,
中心组成部分和参与者之间以及与相关学校之间的合作和协同作用,
Penn/CHOP/Wistar 的部门、中心和研究所,包括 CFAR、CTSA、Delaney Collaboratories
Wistar 和 Temple,以及其他 ARC。核心 A 将参与并负责: 1) 协调跨学科
以及合作心理健康/艾滋病毒研究; 2) 鼓励、支持和指导新的、已建立的和
过渡性调查人员重点关注共病精神疾病/艾滋病毒以及相关共病; 3)开发中
充满活力和反应灵敏的战略规划、监测和评估流程以及综合政策
和程序; 4)管理财务事宜; 5)开展教育和社区外展计划; 6)
促进其他区域委员会之间的国家联系; 7) 支持活跃的社区咨询委员会 (CAB)。
核心 A 还包括 3 名顾问、执行委员会 (EC)、内部顾问委员会 (IAB)、外部顾问
委员会 (EAC)、研究创新与多样性委员会 (RIDC) 和 CAB。这个结构是明确的
旨在进行持续监控和评估,以优化效率和响应能力。
在前两个周期中,PMHARC 在以下方面取得了令人瞩目的进展: 推进多元化/包容性;吸引人的
艾滋病毒/心理健康综合研究和促进研究基础设施的研究人员;识别、
指导和促进早期研究者 (ESI) 的职业发展;并产生令人印象深刻的
试点奖励计划的投资回报。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID S METZGER其他文献
DAVID S METZGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID S METZGER', 18)}}的其他基金
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
- 批准号:
10436808 - 财政年份:2019
- 资助金额:
$ 24.38万 - 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
- 批准号:
10197865 - 财政年份:2019
- 资助金额:
$ 24.38万 - 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
- 批准号:
10654008 - 财政年份:2019
- 资助金额:
$ 24.38万 - 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
- 批准号:
10004224 - 财政年份:2019
- 资助金额:
$ 24.38万 - 项目类别:
Rapid initiation of buprenorphine/naloxone to optimize MAT utilization in Philadelphia
快速启动丁丙诺啡/纳洛酮以优化费城 MAT 的利用
- 批准号:
9896726 - 财政年份:2018
- 资助金额:
$ 24.38万 - 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
- 批准号:
8261981 - 财政年份:2009
- 资助金额:
$ 24.38万 - 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
- 批准号:
7687184 - 财政年份:2009
- 资助金额:
$ 24.38万 - 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
- 批准号:
8085908 - 财政年份:2009
- 资助金额:
$ 24.38万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686543 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709602 - 财政年份:2022
- 资助金额:
$ 24.38万 - 项目类别:
Children's Hospital Los Angeles Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
洛杉矶儿童医院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599558 - 财政年份:2022
- 资助金额:
$ 24.38万 - 项目类别:
Baylor College of Medicine Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
贝勒医学院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599557 - 财政年份:2022
- 资助金额:
$ 24.38万 - 项目类别: